Related Experiment Video

Updated: May 9, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

Immediate metabolic consequences of intrauterine growth restriction and low birthweight

Jatinder Bhatia1, Amy Gates

  • 1Department of Pediatrics, Georgia Health Sciences University, Augusta, GA, USA.

Nestle Nutrition Institute Workshop Series
|July 27, 2013
PubMed

Insights

Optimal fetal growth is crucial for infant health. This study discusses the causes and consequences of fetal growth restriction, low birth weight, and being small for gestational age, impacting millions of newborns globally.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Pediatrics
  • Public Health

Background:

  • Fetal growth restriction impacts millions of infants globally, with an estimated 20 million born with low birthweight.
  • Intrauterine growth restriction (IUGR) is a significant clinical challenge affecting fetal development, survival, and long-term outcomes.
  • Distinguishing between infants small for gestational age (SGA) with normal growth potential and those with true growth restriction is critical for appropriate clinical management.

Purpose of the Study:

  • To discuss the causes of fetal growth restriction, low birthweight, and SGA.
  • To outline the immediate consequences of these conditions on infant survival and development.
  • To highlight the importance of recognizing and managing fetal growth issues.

Main Methods:

  • Review of current understanding of fetal growth restriction.
  • Analysis of factors contributing to low birthweight and SGA.
  • Discussion of the impact of nutrient and oxygen supply limitations on fetal development.

Main Results:

  • Fetal growth restriction is linked to limited nutrient and oxygen supply.
  • Placental changes in growth-restricted pregnancies can lead to circulatory and metabolic alterations.
  • These changes have implications for both short-term survival and long-term development.

Conclusions:

  • Optimal fetal growth is essential for healthy postnatal development.
  • Fetal growth restriction and associated conditions pose significant global health challenges.
  • Understanding the causes and consequences is vital for clinical surveillance and management strategies.

More Related Videos

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...